QPS Acquires JSW Life Sciences, Largest Independent Contract Research Organization in Austria

QPS Acquires JSW Life Sciences, Largest Independent Contract Research Organization in Austria PR Newswire NEWARK, Delaware and GRAMBACH, Austria, Aug. 29, 2012 - Broadens preclinical and Phase II-IV capabilities and increases Central & East European presence NEWARK, Delaware and GRAMBACH, Austria, Aug. 29, 2012 /PRNewswire/ -- QPS, LLC, a leading full-service GLP/GCP- compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the acquisition of a majority interest in JSW Life Sciences GmbH. JSW provides preclinical and clinical Phase II – IV drug development services to pharmaceutical and biotech companies worldwide, and will be known as QPS JSW. JSW has developed its reputation over the past 13 years as a full service, high quality CRO and the leading specialist in CNS diseases including Alzheimer's, Parkinson's, Huntington's, stroke, depression, psychosis and schizophrenia. JSW's reputation in the CNS field is further enhanced by its capabilities in preclinical efficacy studies including in vitro molecular and cellular analysis. JSW is the leading provider of genetically modified organisms for research in CNS diseases and the only company that can combine behavioral analysis (cognition and motoric function), brain neurochemistry and biochemistry as well as quantitative histology and histopathology into preclinical research.